733 related articles for article (PubMed ID: 36872806)
21. MD2 Is a Potential Biomarker Associated with Immune Cell Infiltration in Gliomas.
Zhao M; Li X; Chen Y; Wang S
Front Oncol; 2022; 12():854598. PubMed ID: 35372062
[TBL] [Abstract][Full Text] [Related]
22. High TRAF3IP3 Level Predicts Poor Prognosis of Patients with Gliomas.
Yang G; Tang S; Zhang J; Qin L
World Neurosurg; 2021 Apr; 148():e436-e449. PubMed ID: 33444836
[TBL] [Abstract][Full Text] [Related]
23. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
[TBL] [Abstract][Full Text] [Related]
24. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
Front Oncol; 2022; 12():938679. PubMed ID: 35982954
[TBL] [Abstract][Full Text] [Related]
25. LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma.
Ma W; Bao Z; Qian Z; Zhang K; Fan W; Xu J; Ren C; Zhang Y; Jiang T
CNS Neurosci Ther; 2022 Jun; 28(6):873-883. PubMed ID: 35338570
[TBL] [Abstract][Full Text] [Related]
26. DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients.
Liu F; Tu Z; Liu J; Long X; Xiao B; Fang H; Huang K; Zhu X
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34988580
[TBL] [Abstract][Full Text] [Related]
27. Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas.
Li J; Wang J; Ding Y; Zhao J; Wang W
BMC Cancer; 2022 Apr; 22(1):466. PubMed ID: 35484511
[TBL] [Abstract][Full Text] [Related]
28. Signature Construction and Disulfidptosis-Related Molecular Cluster Identification for Better Prediction of Prognosis in Glioma.
Zhuang Y; Chen J; Mai Z; Huang W; Zhong W
J Mol Neurosci; 2024 Apr; 74(2):38. PubMed ID: 38573391
[TBL] [Abstract][Full Text] [Related]
29. NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Lin Y; Zhang F; Jin Y; Zhong Q; Tan W; Liu J; Wu Z
Appl Bionics Biomech; 2022; 2022():3669296. PubMed ID: 36606241
[TBL] [Abstract][Full Text] [Related]
30. CNPY4 is a potential promising prognostic-related biomarker and correlated with immune infiltrates in gliomas.
Li JW; Huang QR; Mo LG
Medicine (Baltimore); 2022 Aug; 101(33):e30044. PubMed ID: 35984129
[TBL] [Abstract][Full Text] [Related]
31.
Ge X; Xu M; Cheng T; Hu N; Sun P; Lu B; Wang Z; Li J
Front Immunol; 2022; 13():974346. PubMed ID: 36275718
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients.
Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J
Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460
[TBL] [Abstract][Full Text] [Related]
33. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
[No Abstract] [Full Text] [Related]
34. Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas.
Zhu H; Ouyang H; Pan X; Zhang Z; Tan J; Yu N; Li M; Zhao Y
Front Oncol; 2022; 12():912101. PubMed ID: 35875094
[TBL] [Abstract][Full Text] [Related]
35. A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
Xiang Z; Chen X; Lv Q; Peng X
Front Genet; 2021; 12():697819. PubMed ID: 34408772
[TBL] [Abstract][Full Text] [Related]
36. CENPA acts as a prognostic factor that relates to immune infiltrates in gliomas.
Wang B; Wei W; Long S; Wang L; Yang B; Wu D; Li Z; Li Z; Arshad M; Li X; Chen J
Front Neurol; 2022; 13():1015221. PubMed ID: 36341103
[TBL] [Abstract][Full Text] [Related]
37. High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration.
Wang HY; Xie Y; Du H; Luo B; Li Z
PeerJ; 2023; 11():e16104. PubMed ID: 37810780
[TBL] [Abstract][Full Text] [Related]
38. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract][Full Text] [Related]
39. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X
Front Oncol; 2021; 11():682932. PubMed ID: 34123852
[TBL] [Abstract][Full Text] [Related]
40. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]